Annual report
6545.TEDINET S100OGWT
Period2021-04-01 → 2022-03-31
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 106
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥156m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥290m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥287m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥2.8bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥1.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-03-31 | Cons. | Net assets |
| Cash and deposits | ¥1.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥845m | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥272m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥236m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥250m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥34.67 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.74 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥231.64 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 329 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥3.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3.5bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥3.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥148m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥165m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥281m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥250m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥216m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥104m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥279m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥278m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥226m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥187m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥150m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥122m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥65m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥186m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.7bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥853m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥816m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥672m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥845m | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥845m | at 2021-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥930m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥430m | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥405m | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥362m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥395m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥154m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥321m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥104m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥170m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥168m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥248m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥343m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥275m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥39m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥109m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥34.85 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.08 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.96 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.12 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.04 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.91 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.29 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.21 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.64 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.15 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥232.38 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.07 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥160.09 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥150.79 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥133.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.4% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 32.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,427,771 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,427,771 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,427,771 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,413,371 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,017,600 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 296 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 319 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 301 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 292 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 267 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥560m |
| Health Care Solution Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥121m |
| Health Care Solution Businessreportable segment | employees | at 2022-03-31 | 201 pure |
| Health Care Solution Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Health Care Solution Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Health Care Solution Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥338m |
| Home Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥7m |
| Home Care Businessreportable segment | employees | at 2022-03-31 | 91 pure |
| Home Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Home Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Home Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥128m |
| —segment total | employees | at 2022-03-31 | 292 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥716m |
| Health Care Solution Businessreportable segment | employees | at 2022-03-31 | 168 pure |
| Home Care Businessreportable segment | employees | at 2022-03-31 | 91 pure |
| —segment total | employees | at 2022-03-31 | 259 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,037
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 14934 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 3165 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 16 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 29266 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 54252 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 2571 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0806 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0461 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.2753 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0583 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0003 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.5394 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 1040000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1934 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 416000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0774 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 400000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0744 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 248000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0463 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 240000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0446 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 214000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0400 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 150000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0279 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 124000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0232 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 92000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0171 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 85000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0159 | |
| Number of shares held | CurrentYearInstant | 3012000 | |
| Shareholding ratio | CurrentYearInstant | 0.5603 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 51600 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5373600 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 53736 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 2571 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 5427771 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 53736 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 51600 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 51600 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0095 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 51600 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |